Subcutaneous Glutathione for Melasma, Hyperpigmentation & Radiant Tone
The cellular mechanism of converting dark eumelanin to light pheomelanin without toxic bleaching agents
How Does Injectable Glutathione Lighten Hyperpigmentation and Melasma?
Subcutaneous glutathione lightens hyperpigmentation by directly binding copper ions in the active site of tyrosinase, stopping dark eumelanin production. Simultaneously, it conjugates with dopaquinone to drive the synthesis of lighter, golden pheomelanin, visibly clearing melasma and post-inflammatory dark spots. Unlike topical creams that penetrate poorly through the stratum corneum, 503A compounded subcutaneous Glutathione delivers systemic cellular saturation, neutralizing melanocyte oxidative triggers and reversing UV-induced dermal pigmentation from within.
The Melanogenesis Pathway: Eumelanin vs. Pheomelanin
Millions of patients struggling with persistent melasma, chloasma, or post-inflammatory hyperpigmentation (PIH) rely on harsh chemical peels or hydroquinone creams that carry risks of paradoxical darkening (ochronosis). Injectable Glutathione offers an internal, biological mechanism that works synergistically with the body's natural antioxidant defense.
Explore full prescription options on our primary 503A compounded Glutathione program page.
Expert Clinical Perspective:
“Topical skincare products often fail to resolve deep dermal melasma because large active molecules cannot cross the epidermal basement membrane. Injectable subcutaneous glutathione saturates melanocytes systemically, quenching free radical signaling and safely downregulating eumelanin synthesis without the cytotoxicity of traditional bleaches.”